Scalper1 News
Biotech stocks sold off hard Friday as Wall Street blamed a letter by several House Democrats asking Gilead Sciences to justify the price of its hepatitis C blockbuster Sovaldi. The letter, dated Thursday, was signed by Reps. Henry Waxman, Frank Pallone and Diana DeGete, all ranking members of the Committee on Energy and Commerce. It called Sovaldi a “breakthrough” in HCV treatment, but expressed concern that “a treatment will not Scalper1 News
Scalper1 News